Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lilja

Showing results (61-70 of 185) with videos related to

Pageof 19
Sort By:
Journal of Perinatal Medicine|January 1, 1984
Treatment of intrauterine supraventricular tachycardia with digoxin and verapamilH Lilja, K Karlsson, K Lindecrantz, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2J Lövgren, K Rajakoski, M Karp, et al.
Der Urologe. Ausg. A|June 29, 2004
[Isoforms of free prostate-specific antigen]A Haese, J Noldus, T Steuber, et al.
BJU International|February 27, 2004
Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committeeB G Blijenberg, H Lilja, H Neels, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 28, 1999
Decision-making about unwanted pregnancyM Törnbom, E Ingelhammar, H Lilja, et al.
The Journal of Molecular Diagnostics : JMD|August 4, 2001
Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patientsA Ylikoski, M Karp, K Pettersson, et al.
Journal of Psychosomatic Obstetrics and Gynaecology|March 1, 1994
Evaluation of stated motives for legal abortionM Törnbom, E Ingelhammar, H Lilja, et al.
Urology|May 3, 2000
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greaterC Becker, T Piironen, K Pettersson, et al.
Clinical Chemistry|July 27, 2001
Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146P Nurmikko, K Pettersson, T Piironen, et al.
Thrombosis and Haemostasis|August 28, 2001
A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitorK Strandberg, M Kjellberg, R Knebel, et al.
Pageof 19

Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
Journal of Perinatal Medicine|January 1, 1984
Treatment of intrauterine supraventricular tachycardia with digoxin and verapamilH Lilja, K Karlsson, K Lindecrantz, et al.
Biochemical and Biophysical Research Communications|September 23, 1997
Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2J Lövgren, K Rajakoski, M Karp, et al.
Der Urologe. Ausg. A|June 29, 2004
[Isoforms of free prostate-specific antigen]A Haese, J Noldus, T Steuber, et al.
BJU International|February 27, 2004
Quality assessment for prostate-specific antigen (PSA) in relation to ERSPC: report of the PSA committeeB G Blijenberg, H Lilja, H Neels, et al.
Acta Obstetricia Et Gynecologica Scandinavica|July 28, 1999
Decision-making about unwanted pregnancyM Törnbom, E Ingelhammar, H Lilja, et al.
The Journal of Molecular Diagnostics : JMD|August 4, 2001
Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patientsA Ylikoski, M Karp, K Pettersson, et al.
Journal of Psychosomatic Obstetrics and Gynaecology|March 1, 1994
Evaluation of stated motives for legal abortionM Törnbom, E Ingelhammar, H Lilja, et al.
Urology|May 3, 2000
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greaterC Becker, T Piironen, K Pettersson, et al.
Clinical Chemistry|July 27, 2001
Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146P Nurmikko, K Pettersson, T Piironen, et al.
Thrombosis and Haemostasis|August 28, 2001
A sensitive immunochemical assay for measuring the concentration of the activated protein C-protein C inhibitor complex in plasma: use of a catcher antibody specific for the complexed/cleaved form of the inhibitorK Strandberg, M Kjellberg, R Knebel, et al.
Pageof 19